AUMED, a.s. received support for the development of a preparation with phages for recurrent bacterial vaginosis

AUMED received support for the project “Development of an antibacterial preparation with phages for recurrent bacterial vaginosis”, registration number CZ.01.01.01/01/22_002/0000523.

Bacterial vaginosis is a common infectious disease caused by an imbalance in the vaginal microflora, when a reduced proportion of lactobacilli allows other bacteria to multiply. Most often, the bacterium Gardnerella vaginalis overgrows and causes an infection, the symptoms of which are discharge, itching and burning when urinating. In men, this infection can cause inflammation of the prostate or urinary tract.

Bacterial vaginosis is currently most commonly treated with locally acting antibiotics. However, treatment failure and recurrent disease are increasingly common. The number of women for whom antibiotic treatment is not very successful or who have recurring problems is increasing significantly.

The output of the project will be a preparation that will be effective in the therapy of long-term and recurrent vaginosis and will be applicable in the medical field in gynecological specialties. The preparation will be in a pharmaceutical form that allows for easy lay application. At the same time, it will be technologically designed so that neither its composition nor the preparation technology causes degradation of the active ingredient (phage API).

The project will receive financial support from the EU within the Operational Program Technologies and Applications for Competitiveness, Challenges Applications – challenge I.